European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis

J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e241-e242. doi: 10.1111/jdv.16411.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Advisory Committees
  • COVID-19
  • Comorbidity
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / immunology
  • Dermatitis, Atopic / drug therapy
  • Dermatitis, Atopic / epidemiology*
  • Dermatitis, Atopic / immunology
  • Europe
  • Female
  • Humans
  • Immunocompromised Host / drug effects
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / immunology
  • Practice Guidelines as Topic*
  • Risk Assessment
  • Severe Acute Respiratory Syndrome / epidemiology*
  • Severe Acute Respiratory Syndrome / immunology
  • Treatment Outcome

Substances

  • Immunosuppressive Agents